Filing Details
- Accession Number:
- 0001104659-23-026139
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-27 18:08:34
- Reporting Period:
- 2023-02-24
- Accepted Time:
- 2023-02-27 18:08:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1709401 | Rubius Therapeutics Inc. | RUBY | Biological Products, (No Disgnostic Substances) (2836) | 042688109 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1874962 | Dannielle Appelhans | C/O Verdolino &Amp; Lowey, P.c. 124 Washington St. Foxborough MA 02035 | Ceo And President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-02-24 | 10,385 | $0.13 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.1273 to $0.1274, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Billionaire Hedge Funds
